Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mathur

Showing results (461-470 of 463) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 463 results.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Pageof 47

Showing results (461-470 of 463) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 463 results.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptorA V Gavai, P M Sher, A B Mikkilineni, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2001
Beta 3 agonists. Part 1: evolution from inception to BMS-194449W N Washburn, P M Sher, K M Poss, et al.
Pageof 47